Professional Conference

Adam Rosenberg is dedicated to prolonging life and alleviating suffering through nature's gifts. He currently serves as the Chairman of the Board of the National Cannabis Industry Association.

Inspired by the therapeutic potential of cannabis and its derivatives, Adam Rosenberg has dedicated his career to shaping the industry as an operator, investor, advisor, and educator across state-regulated cannabis, biopharmaceuticals, and hemp.

Through Vlasic Bioscience, a cannabis bioscience company founded by the family behind the largest pickle brand, Adam has spearheaded a national strategy to expand safe, affordable access to cannabinoids.

In biopharmaceuticals, he advises executives and manages investment funds for companies pursuing FDA approval for cannabis-derived therapeutics, including AJNA BioSciences, DeFloria, Andira Pharmaceuticals, and Pure Green Pharmaceuticals.

Since 2016, he has operated cultivation, processing, and retail facilities while working with top research and investment firms, including Arcview Group and Tress Capital. Today, he continues to advise investors and funds.

Adam has experience in global practices, including four expeditions to the Himalayas in Nepal since 2018. That same year, he began lobbying for federal reform with NCIA, furthering his commitment to responsible policy development.

His passion for education was fostered at the University of Michigan Ross School of Business, where he founded Green Wolverine, the nation’s first student-led cannabis business organization. Since then, he has collaborated with leading academic institutions and continues to teach at industry events, universities, and law schools.